Mirum Pharmaceuticals, Inc.·4/A

Mar 8, 7:42 PM ET

Clements Ian 4/A

4/A · Mirum Pharmaceuticals, Inc. · Filed Mar 8, 2021

Insider Transaction Report

Form 4/AAmended
Period: 2020-12-23
Clements Ian
SVP Finance & Communications
Transactions
  • Purchase

    Common Stock

    2020-12-23$18.65/sh+1,592$29,6917,871 total
Footnotes (1)
  • [F1]This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION